CoChat

Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle

Open access
Crossland, Hannah, Constantin‐Teodosiu, Dumitru, Greenhaff, Paul L., Gardiner, Sheila M. · 2010 · The Journal of Physiology
Cited by 55

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

We recently provided evidence suggesting a role for cytokine‐mediated inhibition of Akt/Forkhead box O 1 (FOXO1) signalling in the induction of muscle atrophy and impairment of muscle carbohydrate oxidation during lipopolysaccharide (LPS)‐induced endotoxaemia in rats. We hypothesized that a low‐dose dexamethasone (Dex; anti‐inflammatory agent) infusion during endotoxaemia would prevent the LPS‐induced impairment of Akt/FOXO1 signalling, and therefore prevent the muscle atrophy and impairment of carbohydrate oxidation. Chronically instrumented Sprague–Dawley rats received a continuous intravenous infusion of LPS (15 μg kg−1 h−1), Dex (12.5 μg kg−1 h−1), Dex+LPS or saline for 24 h at 0.4 ml h−1. LPS infusion caused haemodynamic changes consistent with a hyperdynamic circulation and induced increases in muscle tumour necrosis factor‐α (TNF‐α; 10‐fold, P < 0.001), interleukin‐6 (IL‐6; 14‐fold, P < 0.001) and metallothionein‐1A (MT‐1A; 187‐fold, P < 0.001) mRNA expression. Dex co‐administration abolished most of the haemodynamic effects of LPS and reduced the increase in muscle TNF‐α, IL‐6 and MT‐1A by 51% (P < 0.01), 85% (P < 0.001) and 58% (P < 0.01), respectively. Dex infusion during endotoxaemia also prevented the LPS‐induced 40% reduction in the muscle protein:DNA ratio and decrease in Akt phosphorylation, and partially prevented the reduction in FOXO1 phosphorylation. However, Dex did not prevent the LPS‐mediated increase in muscle atrophy F‐box (MAFbx) and muscle RING finger 1 (MuRF1) mRNA expression, but did significantly reduce the LPS‐mediated increase in cathepsin‐L mRNA expression and enzyme activity by 43% (P < 0.001) and 53% (P < 0.05), respectively. Furthermore, Dex suppressed LPS‐induced pyruvate dehydrogenase kinase 4 (PDK4) mRNA upregulation by ∼50% (P < 0.01), and prevented LPS‐mediated muscle glycogen breakdown and lactate accumulation. Thus, low‐dose Dex infusion during endotoxaemia prevented muscle atrophy and the impairment of carbohydrate oxidation, potentially through suppression of cytokine‐mediated Akt/FOXO inhibition, and blunting of cathepsin‐L‐mediated lysosomal protein breakdown.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1113/jphysiol.2009.183699

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 55

Metadata

Authors
Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M.
Venue
The Journal of Physiology
Publisher
Wiley
Published
2010-04-14
Volume
588
Issue
8
Pages
1333-1347
ISSN
  • 0022-3751 (ISSN-L)
  • 1469-7793
OpenAlex
W2118958754
Cited by
55
References
9
FWCI
2.01
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. https://app.cochat.ai/papers/10.1113/jphysiol.2009.183699
The paper
Crossland, H., Constantin‐Teodosiu, D., Greenhaff, P. L., & Gardiner, S. M. (2010). Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. The Journal of Physiology. https://doi.org/10.1113/jphysiol.2009.183699

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.